Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 2022;17:515–46.
Google Scholar
Podolanczuk AJ, Thomson CC, Remy-Jardin M, et al. Idiopathic pulmonary fibrosis: state of the Art for 2023. Eur Respir J. 2023;61(4):2200957. [pii].
Google Scholar
Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, Patel H, Kreuter M. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res. 2021;22(1):197. https://doi.org/10.1186/s12931-021-01791-z.
Google Scholar
Khor YH, Ng Y, Barnes H, Goh N, McDonald CF, Holland AE. Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev. 2020;29(157):190158. https://doi.org/10.1183/16000617.0158-2019.
Google Scholar
Castillo-Sánchez JC, Cruz A, Pérez-Gil J. Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challenges. Arch Biochem Biophys. 2021;703108850. https://doi.org/10.1016/j.abb.2021.108850.
Liao Y, Peng X, Yang Y et al. Exploring ABHD5 as a Lipid-Related Biomarker in Idiopathic Pulmonary Fibrosis: Integrating Machine Learning, Bioinformatics, and In Vitro Experiments. Inflammation. 2024.
Saito K, Tanaka N, Ikari J, Suzuki M, Anazawa R, Abe M, Saito Y, Tatsumi K. Comprehensive lipid profiling of bleomycin-induced lung injury. J Appl Toxicol. 2019;39(4):658–71. https://doi.org/10.1002/jat.3758.
Google Scholar
Shi X, Chen Y, Liu Q, Mei X, Liu J, Tang Y, Luo R, Sun D, Ma Y, Wu W, Tu W, Zhao Y, Xu W, Ke Y, Jiang S, Huang Y, Zhang R, Wang L, Chen Y, Xia J, Pu W, Zhu H, Zuo X, Li Y, Xu J, Gao F, Wei D, Chen J, Yin W, Wang Q, Dai H, Yang L, Guo G, Cui J, Song N, Zou H, Zhao S, Distler J, Jin L, Wang J. LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis. Clin Transl Med. 2022;12(1):e711. https://doi.org/10.1002/ctm2.711.
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007.
Google Scholar
Kim S, Herazo-Maya JD, Kang DD et al. Integrative phenotyping framework (iPF): integrative clustering of multiple omics data identifies novel lung disease subphenotypes. BMC Genomics. 2015;16924.
Yang IV, Coldren CD, Leach SM, et al. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax. 2013;68(12):1114–21.
Google Scholar
DePianto DJ, Chandriani S, Abbas AR, et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax. 2015;70(1):48–56.
Google Scholar
Furusawa H, Cardwell JH, Okamoto T, et al. Chronic hypersensitivity pneumonitis, an interstitial lung disease with distinct molecular signatures. Am J Respir Crit Care Med. 2020;202(10):1430–44.
Google Scholar
Prasse A, Binder H, Schupp JC, Kayser G, Bargagli E, Jaeger B, et al. BAL cell gene expression is indicative of outcome and airway basal cell involvement in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(5):622–30. https://doi.org/10.1164/rccm.201712-2551OC.
Google Scholar
Herazo-Maya JD, Noth I, Duncan SR, et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med. 2013;5(205):205ra136.
Google Scholar
Huang Y, Ma SF, Vij R et al. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med. 2015;15147.
Molyneaux PL, Willis-Owen S, Cox MJ, et al. Host-Microbial interactions in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2017;195(12):1640–50.
Google Scholar
Stelzer G, Rosen N, Plaschkes I et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016;541.30.1–1.30.33.
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.
Google Scholar
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9559.
Schriml LM, Munro JB, Schor M, et al. The human disease ontology 2022 update. Nucleic Acids Res. 2022;50(D1):D1255–61.
Google Scholar
Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049–1056.
Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
Google Scholar
Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–46.
Google Scholar
Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.
Google Scholar
Liao Y, Peng X, Yang Y, et al. Integrating cellular experiments, single-cell sequencing, and machine learning to identify Endoplasmic reticulum stress biomarkers in idiopathic pulmonary fibrosis. Ann Med. 2024;56(1):2409352.
Google Scholar
Stuart T, Butler A, Hoffman P, et al. Comprehensive integration of Single-Cell data. Cell. 2019;177(7):1888–e190221.
Google Scholar
Korsunsky I, Millard N, Fan J, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289–96.
Google Scholar
Feng A, Caro YM, Gardner C, et al. PTK2-associated gene signature could predict the prognosis of IPF. Respir Res. 2023;24(1):304.
Google Scholar
Xia Y, Lei C, Yang D et al. Construction and validation of a Bronchoalveolar lavage cell-associated gene signature for prognosis prediction in idiopathic pulmonary fibrosis. Int Immunopharmacol. 2021;92107369.
Li X, Cai H, Cai Y et al. Investigation of a Hypoxia-Immune-Related microenvironment gene signature and prediction model for idiopathic pulmonary fibrosis. Front Immunol. 2021;12629854.
Lyu Y, Guo C, Zhang H. Fatty acid metabolism-related genes in Bronchoalveolar lavage fluid unveil prognostic and immune infiltration in idiopathic pulmonary fibrosis. Front Endocrinol (Lausanne). 2022;131001563.
Zheng J, Dong H, Zhang T et al. Development and validation of a novel gene signature for predicting the prognosis of idiopathic pulmonary fibrosis based on three Epithelial-Mesenchymal transition and Immune-Related genes. Front Genet. 2022;13865052.
Fan G, Liu J, Wu Z et al. Development and validation of the prognostic model based on autophagy-associated genes in idiopathic pulmonary fibrosis. Front Immunol. 2022;131049361.
Qiu L, Gong G, Wu W, et al. A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes. Ann Transl Med. 2021;9(20):1570.
Google Scholar
Liao Y, Yang Y, Zhou G, et al. Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation. Expert Rev Clin Immunol. 2024;20(6):679–93.
Google Scholar
Li M, Wang K, Zhang Y et al. Ferroptosis-Related genes in Bronchoalveolar lavage fluid serves as prognostic biomarkers for idiopathic pulmonary fibrosis. Front Med (Lausanne). 2021;8693959.
He Y, Shang Y, Li Y, et al. An 8-ferroptosis-related genes signature from Bronchoalveolar lavage fluid for prognosis in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2022;22(1):15.
Google Scholar
Liu J, Gu L, Li W. The prognostic value of integrated analysis of inflammation and Hypoxia-Related genes in idiopathic pulmonary fibrosis. Front Immunol. 2022;13730186.
Guo R, Zhou Y, Lin F et al. A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis. Front Pharmacol. 2022;13981604.
Zhu H, Zhou A, Zhang M et al. Comprehensive analysis of an Endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis. Front Immunol. 2023;141305025.
Zhou M, Ouyang J, Zhang G, et al. Prognostic value of tripartite motif (TRIM) family gene signature from Bronchoalveolar lavage cells in idiopathic pulmonary fibrosis. BMC Pulm Med. 2022;22(1):467.
Google Scholar
Liu B, Zhang X, Liu Z, et al. A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on Endoplasmic reticulum stress-related genes. Cell Biol Int. 2024;48(4):483–95.
Google Scholar
Zhang H, Yang Y, Cao Y, et al. IPF-related new macrophage subpopulations and diagnostic biomarker identification – combine machine learning with single-cell analysis. Respir Res. 2024;25(1):241.
Google Scholar
He J, Hu J, Liu H. A three-gene random forest model for diagnosing idiopathic pulmonary fibrosis based on circadian rhythm-related genes in lung tissue. Expert Rev Respir Med. 2023;17(12):1307–20.
Google Scholar
Jing C, Fu R, Liu X et al. A comprehensive Cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis. Front Immunol. 2023;141268141.
Lee T, Ahn SY, Kim J, et al. Deep learning-based prognostication in idiopathic pulmonary fibrosis using chest radiographs. Eur Radiol. 2024;34(7):4206–17.
Google Scholar
Lee J, Arisi I, Puxeddu E, Mramba LK, Amicosante M, Swaisgood CM, et al. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation. PLoS ONE. 2018;13(4):e0194803. https://doi.org/10.1371/journal.pone.0194803.
Google Scholar
He Z, He J, Xie K. KLF4 transcription factor in tumorigenesis. Cell Death Discov. 2023;9(1):118.
Google Scholar
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.
Google Scholar
Zhang R, Wang H, Cheng X, et al. High Estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis. Aging. 2024;16(11):9876–98.
Google Scholar
Liao X, Sharma N, Kapadia F, et al. Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121(7):2736–49.
Google Scholar
Yang Y, Wei S, Li Q et al. Vitamin D protects silica particles induced lung injury by promoting macrophage polarization in a KLF4-STAT6 manner. J Nutr Biochem. 2022;110109148.
Shao X, Xu P, Ji L, et al. Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter. Clin Transl Med. 2023;13(7):e1344.
Google Scholar
Ye Q, Luo F, Yan T. Transcription factor KLF4 regulated STAT1 to promote M1 polarization of macrophages in rheumatoid arthritis. Aging. 2022;14(14):5669–80.
Google Scholar
Wei S, Qi F, Wu Y, et al. Overexpression of KLF4 suppresses pulmonary fibrosis through the HIF-1α/Endoplasmic reticulum stress signaling pathway. Int J Mol Sci. 2023;24(18):14008.
Google Scholar
Wang H, Xu H, Lyu W, et al. KLF4 regulates TERT expression in alveolar epithelial cells in pulmonary fibrosis. Cell Death Dis. 2022;13(5):435.
Google Scholar
Lin L, Han Q, Xiong Y, et al. Krüpple-like-factor 4 attenuates lung fibrosis via inhibiting Epithelial-mesenchymal transition. Sci Rep. 2017;7(1):15847.
Google Scholar
Rui Y, Han X, Jiang A et al. Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. Eur J Pharmacol. 2022;931175184.
